Portfolio news 0

Iksuda Therapeutics Ltd

Iksuda presents encouraging IKS014 Phase 1 data at ESMO

Artios Pharma

Artios Announces Phase 1/2a Data for DNA Polymerase Theta Inhibitor ART6043 at ESMO Congress 2025

Genomics

Genomics launches Mystra: the world’s first and original AI-enabled human genetics platform, now available to transform drug target discovery and clinical development

Mission Therapeutics Limited

Mission Therapeutics raises $13.3 million to progress first-in-class Parkinson’s disease candidate MTX325 through clinical trials

Akamis Bio

Akamis Bio Receives FDA Fast Track Designation for NG-350A for the Treatment of Mismatch Repair-Proficient Locally Advanced Rectal Cancer

Iksuda Therapeutics Ltd

Iksuda to present IKS014 Phase 1 data at ESMO

Artios Pharma

Artios to Announce First Phase 1/2a Data for DNA Polymerase Theta (Polθ) Inhibitor ART6043 in Advanced Solid Tumors in Oral Presentation at ESMO

Monolith

CoreWeave to Acquire Monolith, Expanding AI Cloud Platform into Industrial Innovation

Accelercomm Ltd

AccelerComm and Radisys Secure Funding from UK Space Agency for Next Generation 5G Satellites

OXCCU

OXCCU raises $28m in series B funding to scale sustainable aviation fuel from waste carbon